Validation of a multi-omics strategy for prioritizing personalized candidate driver genes

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Tumor heterogeneity complicates the identification of cancer driver genes, particularly for personalized medicine.
• Previous work prioritized five candidate mutation-driver genes in a hyper-mutated hepatocellular carcinoma patient using a multi-omics approach.

Purpose of the Study:

• To elucidate the functional roles of prioritized driver genes and patient-specific mutations in hepatocarcinogenesis.
• To investigate the impact of tumor-mutated alleles on protein structure-function relationships.
• To assess the in vitro effects of loss- and gain-of-function mutations on hepatoma cell behaviors.

Main Methods:

• Analysis of the structure-function relationship of proteins encoded by tumor-mutated alleles.
• In vitro functional assays evaluating cell proliferation and migration.
• Assessment of gene and mutation effects on hepatoma cell behaviors.

Main Results:

• Prioritized mutation-driver genes function as tumor suppressors, inhibiting cell proliferation and migration.
• Patient-specific mutations with a loss-of-function effect enhanced cell proliferation and migration.
• The HNF1A S247T mutation reduced HNF1A transcriptional activity for HNF4A without affecting HNF1A nuclear localization.

Conclusions:

• The findings support the efficacy of the proposed multi-omics strategy for prioritizing mutation-drivers.
• This approach offers a novel pathway for developing personalized cancer therapies.